Rebecca L. Porter1 article listing Rebecca L. Porter in Nature Communications, indexed by Paperzzz from Crossref and OSF.Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial Nature Communications